FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/21/2025
Back to search
Official data from USPTO
AXITHRA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
AXITHRA
ST13
US500000079376834Class
9, 10, 42
Filing
79376834
Registration
7592484
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
04/03/2026
Classification
Registered
Trademark type
Word
Nice classes
9, 10, 42
Filing date
03/23/2023
Registration date
12/10/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/10/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
BE
Examiner
BLANE, SUZANNE
Law office
M50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Axithra BV
I. V. (pessoa física)
Representatives
Elizabeth A. Cominolli Markert & Cominolli PLLC
Technical classification
Nice Classes
Class 9Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Research laboratory analyzers for measuringtesting and analyzing blood and other bodily fluids; photonic detectorsphoton detectors for measuring and monitoring drug concentrations and drug effectiveness in biological samplesbloodother bodily fluids; silicon chips; downloadable computer software relating to the medical fieldcomputer software for measuring and monitoring drug concentrations and drug effectiveness in biological samplesbloodother bodily fluids; measuringdetectingmonitoring and controlling devicesresearch laboratory analyzers for measuringtesting and analyzing biological samplesblood and other bodily fluids; sensorsdetectors and monitoring instrumentsphotonic sensorsphoton detectorsmonitoring instruments for photonic detection and signal transmission; monitoring apparatus and instrumentsmonitoring devices for monitoring drug concentrations and drug effectiveness in biological samplesblood and other bodily fluids
Class 10
Medical instruments for therapeutic drug monitoring; photo electron spectroscopy analyzers for medical purposes; x-ray spectroscopy apparatus for medical use; patient monitoring instrumentsmedical instruments for measuring and monitoring drug concentrations and drug effectiveness in blood and other bodily fluids; diagnosticexaminationmonitoring equipmentmedical apparatus for measuring and monitoring drug concentrations and drug effectiveness in blood and other bodily fluids; electronic monitoring instruments for medical usemedical instruments for measuring and monitoring drug concentrations and drug effectiveness in blood and other bodily fluids; sensor apparatus for medical use in diagnosispatient sensors for measuring and monitoring drug concentrations and drug effectiveness in blood and other bodily fluids; electro-medical appliances for medical purposesmedical instruments for measuring and monitoring drug concentrations and drug effectiveness in blood and other bodily fluids; medical apparatus for drug administrationmedical apparatus for intravenous administration of medicines
Class 42
Product research and development services; pharmaceutical research and development services; medical and pharmacological research services; design and development of medical technology; design and development of medical diagnostic apparatus; design and development of medical monitoring apparatus; design and development of computer software for use with medical technology
Publications
History of USPTO decisions and trademark events.
28 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
05/12/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
05/12/2025
CHLD
CHANGE OF OWNER RECEIVED FROM IB
05/01/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/14/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/10/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/27/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/27/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/10/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/10/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/08/2024
PUBO
PUBLISHED FOR OPPOSITION
10/08/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/18/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/03/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/09/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/09/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/09/2024
RFNT
REFUSAL PROCESSED BY IB
01/31/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/11/2024
RFRR
REFUSAL PROCESSED BY MPU
01/11/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/29/2023
CNRT
NON-FINAL ACTION WRITTEN
12/28/2023
DOCK
ASSIGNED TO EXAMINER
12/19/2023
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
10/10/2023
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
10/02/2023
MAFR
APPLICATION FILING RECEIPT MAILED
08/22/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/18/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/17/2023
Continuous trademark protection
Get notified about every new filing that threatens AXITHRA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.